每经头条（nbdtoutiao）——中国创新药，今年海外授权已卖出800亿美元！对话创东方投资合伙人卢 刚：生物医药二级市场火热，一级市场为何募资遇冷？ 2024年1至12月份，湖南海利的营业收入构成为：农药制剂占比91.15%，锂电电池占比8.85%。 截至发稿，湖南海利市值为42亿元。 每经AI快讯，湖南海利（SH 600731，收盘价：7.46元）10月23日晚间发布公告称，公司第十届二十四 次董事会会议于2025年10月23日在长沙市采用现场和通讯结合表决方式召开。会议审议了《关于调整公 司2025年限制性股票激励计划相关事项的议案》等文件。 （记者 曾健辉） ...

Group 1 - The company Hunan Haili announced a share buyback of approximately 3.2 million shares, representing 0.5721% of its total share capital, with a total expenditure of about 22.26 million RMB [1] - The highest and lowest prices for the repurchased shares were 7.01 RMB and 6.88 RMB per share, respectively [1] - For the year 2024, the company's revenue composition is 91.15% from pesticide formulations and 8.85% from lithium batteries [1] Group 2 - The current market capitalization of Hunan Haili is 4.1 billion RMB [2]

Group 1 - Hunan Haili announced the convening of its 22nd meeting of the 10th Board of Directors on August 22, 2025, in Changsha, discussing the 2025 semi-annual report [1] - For the year 2024, Hunan Haili's revenue composition is 91.15% from pesticide formulations and 8.85% from lithium batteries [1] Group 2 - As of the report, Hunan Haili has a market capitalization of 4.5 billion yuan [2]